Works by Jalving, Mathilde

Results: 29

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.

Published in:

Cancers, 2023, v. 15, n. 11, p. 2922, doi. 10.3390/cancers15112922

By:

van Not, Olivier J.;
Wind, Thijs T.;
Ismail, Rawa K.;
Bhattacharya, Arkajyoti;
Jalving, Mathilde;
Blank, Christian U.;
Aarts, Maureen J. B.;
van den Berkmortel, Franchette W. P. J.;
Boers-Sonderen, Marye J.;
van den Eertwegh, Alfonsus J. M.;
de Groot, Jan Willem B.;
Haanen, John B.;
Kapiteijn, Ellen;
Bloem, Manja;
Piersma, Djura;
van Rijn, Rozemarijn S.;
Stevense-den Boer, Marion;
van der Veldt, Astrid A. M.;
Vreugdenhil, Gerard;
Wouters, Michel W. J. M.

Publication type:

Article

Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer.

Published in:

Cancers, 2022, v. 14, n. 6, p. 1511, doi. 10.3390/cancers14061511

By:

de Witte, Chris J.;
Kutzera, Joachim;
van Hoeck, Arne;
Nguyen, Luan;
Boere, Ingrid A.;
Jalving, Mathilde;
Ottevanger, Petronella B.;
van Schaik-van de Mheen, Christa;
Stevense, Marion;
Kloosterman, Wigard P.;
Zweemer, Ronald P.;
Cuppen, Edwin;
Witteveen, Petronella O.

Publication type:

Article

Type 2 Diabetes Mellitus and Clinicopathological Tumor Characteristics in Women Diagnosed with Breast Cancer: A Systematic Review and Meta-Analysis.

Published in:

Cancers, 2021, v. 13, n. 19, p. 4992, doi. 10.3390/cancers13194992

By:

Zhang, Fan;
de Haan-Du, Jing;
Sidorenkov, Grigory;
Landman, Gijs W. D.;
Jalving, Mathilde;
Zhang, Qingying;
de Bock, Geertruida H.

Publication type:

Article

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases.

Published in:

2022

By:

Eggen, Annemarie C.;
Hospers, Geke A. P.;
Bosma, Ingeborg;
Kramer, Miranda C. A.;
Reyners, Anna K. L.;
Jalving, Mathilde

Publication type:

journal article

The BRAF P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning.

Published in:

Journal of Personalized Medicine, 2021, v. 11, n. 4, p. 257, doi. 10.3390/jpm11040257

By:

Angus, Lindsay;
Starmans, Martijn P. A.;
Rajicic, Ana;
Odink, Arlette E.;
Jalving, Mathilde;
Niessen, Wiro J.;
Visser, Jacob J.;
Sleijfer, Stefan;
Klein, Stefan;
van der Veldt, Astrid A. M.

Publication type:

Article

Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.

Published in:

Cell Death & Disease, 2022, v. 13, n. 6, p. 1, doi. 10.1038/s41419-022-05005-2

By:

Zois, Christos E.;
Hendriks, Anne M.;
Haider, Syed;
Pires, Elisabete;
Bridges, Esther;
Kalamida, Dimitra;
Voukantsis, Dimitrios;
Lagerholm, B. Christoffer;
Fehrmann, Rudolf S. N.;
den Dunnen, Wilfred F. A.;
Tarasov, Andrei I.;
Baba, Otto;
Morris, John;
Buffa, Francesca M.;
McCullagh, James S. O.;
Jalving, Mathilde;
Harris, Adrian L.

Publication type:

Article

Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.

Published in:

2017

By:

Ariaans, Gerke;
Jalving, Mathilde;
de Vries, Emma Geertruida Elisabeth;
de Jong, Steven;
Vries, Emma Geertruida Elisabeth de;
Jong, Steven de

Publication type:

journal article

Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study.

Published in:

2020

By:

Oude Elberink, Hanneke N. G.;
Jalving, Mathilde;
Dijkstra, Hilda;
van de Ven, Annick A. J. M.

Publication type:

Letter

Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations.

Published in:

Molecular Imaging & Biology, 2023, v. 25, n. 2, p. 435, doi. 10.1007/s11307-022-01775-5

By:

van Sluis, Joyce;
Noordzij, Walter;
de Vries, Elisabeth G. E.;
Kok, Iris C.;
de Groot, Derk Jan A.;
Jalving, Mathilde;
Lub-de Hooge, Marjolijn N.;
Brouwers, Adrienne H.;
Boellaard, Ronald

Publication type:

Article

B cells critical for outcome in high grade serous ovarian carcinoma.

Published in:

International Journal of Cancer, 2024, v. 155, n. 12, p. 2265, doi. 10.1002/ijc.35149

By:

Vledder, Annegé;
Paijens, Sterre T.;
Loiero, Dominik;
Maagdenberg, Alexis;
Duiker, Evelien W.;
Bart, Joost;
Hendriks, Anne M.;
Jalving, Mathilde;
Werner, Naomi;
van Rooij, Nienke;
Plat, Annechien;
Wisman, G. Bea A.;
Yigit, Refika;
Roelofsen, Thijs;
Kruse, Arnold J.;
de Lange, Nastascha M.;
Koelzer, Viktor H.;
de Bruyn, Marco;
Nijman, Hans W.

Publication type:

Article

Effect of veliparib (ABT-888) on cardiac repolarization in patients with advanced solid tumors: a randomized, placebo-controlled crossover study.

Published in:

2016

By:

Munasinghe, Wijith;
Stodtmann, Sven;
Tolcher, Anthony;
Calvo, Emiliano;
Gordon, Michael;
Jalving, Mathilde;
Vos-Geelen, Judith;
Medina, Diane;
Bergau, Dennis;
Nuthalapati, Silpa;
Hoffman, David;
Shepherd, Stacie;
Xiong, Hao;
de Vos-Geelen, Judith

Publication type:

journal article

Molecular Imaging in Cancer Drug Development.

Published in:

Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 726, doi. 10.2967/jnumed.116.188045

By:

Waaijer, Stijn J. H.;
Kok, Iris C.;
Eisses, Bertha;
Schröder, Carolina P.;
Jalving, Mathilde;
Brouwers, Adrienne H.;
Lub-de Hooge, Marjolijn N.;
de Vries, Elisabeth G. E.

Publication type:

Article

Theranostics Using Antibodies and Antibody-Related Therapeutics.

Published in:

Journal of Nuclear Medicine, 2017, v. 58, p. 83S, doi. 10.2967/jnumed.116.186940

By:

Moek, Kirsten L.;
Giesen, Danique;
Kok, Iris C.;
de Groot, Derk Jan A.;
Jalving, Mathilde;
Fehrmann, Rudolf S. N.;
Lub-de Hooge, Marjolijn N.;
Brouwers, Adrienne H.;
de Vries, Elisabeth G. E.

Publication type:

Article

Therapeutic targeting and patient selection for cancers with homologous recombination defects.

Published in:

Expert Opinion on Drug Discovery, 2017, v. 12, n. 6, p. 565, doi. 10.1080/17460441.2017.1322061

By:

Talens, Francien;
Jalving, Mathilde;
Gietema, Jourik A.;
Van Vugt, Marcel A.

Publication type:

Article

Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3745, doi. 10.3390/ijms23073745

By:

Tiersma, Jiske F.;
Evers, Bernard;
Bakker, Barbara M.;
Jalving, Mathilde;
de Jong, Steven

Publication type:

Article

Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis.

Published in:

Virchows Archiv: European Journal of Pathology, 2021, v. 479, n. 6, p. 1119, doi. 10.1007/s00428-021-03170-x

By:

Hone Lopez, Sara;
Kats-Ugurlu, Gursah;
Renken, Remco J.;
Buikema, Henk J.;
de Groot, Marco R.;
Visschedijk, Marijn C.;
Dijkstra, Gerard;
Jalving, Mathilde;
de Haan, Jacco J.

Publication type:

Article

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 13, p. 4369, doi. 10.1007/s00259-021-05407-y

By:

van de Donk, Pim P.;
Wind, Thijs T.;
Hooiveld-Noeken, Jahlisa S.;
van der Veen, Elly L.;
Glaudemans, Andor W. J. M.;
Diepstra, Arjan;
Jalving, Mathilde;
de Vries, Elisabeth G. E.;
de Vries, Erik F. J.;
Hospers, Geke A. P.

Publication type:

Article

Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1498, doi. 10.1007/s00259-020-05068-3

By:

van Sluis, Joyce;
de Heer, Ellen C.;
Boellaard, Mayke;
Jalving, Mathilde;
Brouwers, Adrienne H.;
Boellaard, Ronald

Publication type:

Article

Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer.

Published in:

Neuro-Oncology Practice, 2022, v. 9, n. 1, p. 50, doi. 10.1093/nop/npab056

By:

Eggen, Annemarie C;
Richard, Nadine M;
Bosma, Ingeborg;
Jalving, Mathilde;
Leighl, Natasha B;
Liu, Geoffrey;
Mah, Kenneth;
Higazy, Randa;
Shultz, David B;
Reyners, Anna K L;
Rodin, Gary;
Edelstein, Kim

Publication type:

Article

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis.

Published in:

EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0453-x

By:

de Heer, Ellen C.;
Brouwers, Adrienne H.;
Boellaard, Ronald;
Sluiter, Wim J.;
Diercks, Gilles F. H.;
Hospers, Geke A. P.;
de Vries, Elisabeth G. E.;
Jalving, Mathilde

Publication type:

Article

Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma.

Published in:

Cancer Medicine, 2021, v. 10, n. 23, p. 8395, doi. 10.1002/cam4.4342

By:

Eggen, Annemarie C.;
Wind, Thijs T.;
Bosma, Ingeborg;
Kramer, Miranda C. A.;
van Laar, Peter Jan;
van der Weide, Hiska L.;
Hospers, Geke A. P.;
Jalving, Mathilde

Publication type:

Article

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement.

Published in:

Rheumatology, 2025, v. 64, n. 2, p. 771, doi. 10.1093/rheumatology/keae099

By:

Vermeulen, Olof C B;
Brouwer, Elisabeth;
Slart, Riemer H J A;
Sandovici, Maria;
Rutgers, Abraham;
Hilterman, T Jeroen;
Hiddinga, Birgitta;
Oosting, Sjoukje F;
Jalving, Mathilde;
Heij, Albert H de;
Knapen, Daan G;
Hospers, Geke A P;
Geest, Kornelis S M van der

Publication type:

Article

18F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262368

By:

Nienhuis, Pieter H.;
Antunes, Inês F.;
Glaudemans, Andor W. J. M .;
Jalving, Mathilde;
Leung, David;
Noordzij, Walter;
Slart, Riemer H. J. A.;
de Vries, Erik F. J.;
Hospers, Geke A. P.

Publication type:

Article

18F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262368

By:

Nienhuis, Pieter H.;
Antunes, Inês F.;
Glaudemans, Andor W. J. M.;
Jalving, Mathilde;
Leung, David;
Noordzij, Walter;
Slart, Riemer H. J. A.;
de Vries, Erik F. J.;
Hospers, Geke A. P.

Publication type:

Article

18F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262368

By:

Nienhuis, Pieter H.;
Antunes, Inês F.;
Glaudemans, Andor W. J. M.;
Jalving, Mathilde;
Leung, David;
Noordzij, Walter;
Slart, Riemer H. J. A.;
de Vries, Erik F. J.;
Hospers, Geke A. P.

Publication type:

Article

A Phase I, First‐in‐Human Study of GSK2849330, an Anti‐HER3 Monoclonal Antibody, in HER3‐Expressing Solid Tumors.

Published in:

Oncologist, 2021, v. 26, n. 10, p. e1844, doi. 10.1002/onco.13860

By:

Gan, Hui K.;
Millward, Michael;
Jalving, Mathilde;
Garrido‐Laguna, Ignacio;
Lickliter, Jason D.;
Schellens, Jan H.M.;
Lolkema, Martijn P.;
Van Herpen, Carla L.M.;
Hug, Bruce;
Tang, Lihua;
O'Connor‐Semmes, Robin;
Gagnon, Robert;
Ellis, Catherine;
Ganji, Gopinath;
Matheny, Christopher;
Drilon, Alexander

Publication type:

Article

PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability.

Published in:

PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230901

By:

Pfaehler, Elisabeth;
Burggraaff, Coreline;
Kramer, Gem;
Zijlstra, Josée;
Hoekstra, Otto S.;
Jalving, Mathilde;
Noordzij, Walter;
Brouwers, Adrienne H.;
Stevenson, Marc G.;
de Jong, Johan;
Boellaard, Ronald

Publication type:

Article

Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer.

Published in:

Investigational New Drugs, 2020, v. 38, n. 5, p. 1454, doi. 10.1007/s10637-020-00920-7

By:

Broekman, K. Esther;
Hof, Marieke A. J.;
Touw, Daan J.;
Gietema, Jourik A.;
Nijman, Hans W.;
Lefrandt, Joop D.;
Reyners, An K. L.;
Jalving, Mathilde

Publication type:

Article

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer.

Published in:

2020

By:

de Heer, Ellen C.;
Jalving, Mathilde;
Harris, Adrian L.

Publication type:

journal article

Works by Jalving, Mathilde

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.

Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer.

Type 2 Diabetes Mellitus and Clinicopathological Tumor Characteristics in Women Diagnosed with Breast Cancer: A Systematic Review and Meta-Analysis.

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases.

The BRAF P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning.

Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.

Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.

Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study.

Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations.

B cells critical for outcome in high grade serous ovarian carcinoma.

Effect of veliparib (ABT-888) on cardiac repolarization in patients with advanced solid tumors: a randomized, placebo-controlled crossover study.

Molecular Imaging in Cancer Drug Development.

Theranostics Using Antibodies and Antibody-Related Therapeutics.

Therapeutic targeting and patient selection for cancers with homologous recombination defects.

Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities.

Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis.

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy.

Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma.

Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer.

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative <sup>18</sup>F-FDG PET/CT analysis.

Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma.

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement.

<sup>18</sup>F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.

<sup>18</sup>F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.

<sup>18</sup>F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.

A Phase I, First‐in‐Human Study of GSK2849330, an Anti‐HER3 Monoclonal Antibody, in HER3‐Expressing Solid Tumors.

PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability.

Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer.

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer.